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Abstract This study examines the prevalence of anxiety
disorders in children with Williams syndrome (WS), their
sibling closest in age, and their mothers as well as the
predictors of anxiety in these groups. The prevalence of
anxiety disorders was assessed and compared to that in the
general population. Children with WS had a significantly
higher prevalence of specific phobia, generalized anxiety
disorder (GAD), and separation anxiety in comparison to
children in the general population. While mothers had a
higher prevalence of GAD than population controls, the
excess was accounted for by mothers who had onset after
the birth of their WS child. The siblings had rates similar to
the general population. This pattern of findings suggests the
presence of a gene in the WS region whose deletion
predisposes to anxiety disorders. It is also worthwhile to
investigate relations between genes deleted in WS and
genes previously implicated in anxiety disorders.
Keywords Genetics.Anxiety.Family.Mentalretardation.
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Anxiety disorders are among the most common psychiatric
disorders, with a lifetime prevalence of approximately 25%
in adults [1] and 4–9% in children [2, 3]. Moreover, many
adult anxiety disorders have their onset in childhood or
adolescence and may have a chronic course [e.g., 4, 5].
They are also highly co-morbid with each other and other
psychiatric disorders, especially with mood disorders [e.g.,
6] and are associated with high levels of occupational and
social impairment [e.g., 7].
The Diagnostic and Statistical Manual of Psychiatric
Disorders (DSM-IV-TR) [8] specifies the following types of
anxiety disorders in children and adults: separation anxiety,
panic disorder (PD), agoraphobia, specific phobia, social
phobia, generalized anxiety disorder (GAD), obsessive-
compulsive disorder (OCD), post-traumatic stress disorder
(PTSD), and acute stress disorder (Table 1).
Given their high prevalence and the accompanying
impairment, the etiology of anxiety disorders is of major
interest and importance. It has been investigated through a
number of genetic approaches, including family studies,
which provide information about the familial aggregation of
the disorder [9]; twin studies, which investigate heritability
of the disorder by comparing the concordance rate for a
specific condition in pairs of monozygotic (MZ) and
dizygotic (DZ) twins [9]; and association and linkage
studies, which seek to identify specific genes or chromo-
somal regions related to anxiety disorders [10].
Family studies of anxiety disorders [11–13]h a v e
demonstrated familiality of specific anxiety disorders.
Familial aggregation of anxiety disorders in general has
been demonstrated as well. For example, Merikangas and
colleagues [14–16] found that the risk of developing an
anxiety disorder in children aged 7–17 years was three
times as high if a parent had an anxiety disorder as if a
parent had a substance abuse disorder or neither parent had
a psychiatric diagnosis. Turner, Bidel, and Costello [17]
found that children of parents with anxiety disorders were
seven times more likely to develop an anxiety disorder than
children of control parents without a psychiatric diagnosis.
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been conducted [18–21]. In most studies the concordance
rates were higher for MZ twins than for DZ twins. Hettema
et al. [22], in a meta-analysis of twin studies of anxiety
disorders, estimated 30–40% heritability for anxiety dis-
orders, depending on the disorder.
Multiple molecular genetic studies of anxiety disorders
have been conducted as well, including linkage and
association studies. Although several candidate chromo-
somal regions, genes, and polymorphisms have been linked
to anxiety disorders [reviewed in 10], many of the initial
findings are conflicting, and no specific genes have been
identified thus far. This is not surprising; although anxiety
disorders aggregate in families, their mode of inheritance
does not follow a clear Mendelian pattern (i.e., dominant,
recessive, or X-linked). Instead, these are complex disor-
ders that appear to be caused by an interaction among a
variety of genes as well as environmental factors [23].
Additionally, because the pathophysiology of anxiety
disorders remains unclear, choosing candidate genes for
association studies is not easy.
A number of chromosomal and genetic disorders caused
by deletions, trisomies, or translocations are associated with
specific behavioral characteristics, referred to as behavioral
phenotypes [24]. Although these behavioral characteristics
may include psychiatric features, the complete profiles of
psychiatric features and their risk factors in these disorders
are unknown. Examination of genetic neurodevelopmental
disorders associated with high prevalence rates of a
particular psychiatric disorder may provide a complemen-
tary approach in the search for susceptibility genes for
complex disorders [25]. Association studies can be con-
ducted using the genetic markers on the locus or the genes
implicated in the chromosomal abnormality. Also, hypoth-
eses may be made about the interaction of the chromosomal
region involved in the abnormality and genes that have
already been implicated in these disorders in previous
studies.
Karayiorgou and Gogos [26] state that to determine
reliably a causal relation between a chromosomal abnor-
mality and a disease, one or preferably both of the
following criteria must be demonstrated: 1) increased
frequency of the disease in a population with the chromo-
somal abnormality and 2) increased frequency of the
chromosomal abnormality in the population with the
disease. Studies of complex disorders such as schizophrenia
and Alzheimer disorder [e.g., 25, 27, 28] have demonstrat-
ed the success of this approach. For example, findings of
elevated prevalence of schizophrenia in individuals with
22q11 deletion syndrome have prompted genetic linkage
and association studies of schizophrenia on chromosome
22q, which have led to finding a potential schizophrenia
susceptibility locus on chromosome 22q [reviewed in 25].
Similar strategies can be applied to genetic studies of
anxiety disorders.
Williams syndrome (WS) is a neurodevelopmental disor-
der caused by a microdeletion of ~25 genes on chromosome
7q11.23 [29, 30]. It is associated with mild to moderate
intellectual disability or learning difficulties, a characteristic
facies, heart disease (especially supravalvar aortic stenosis),
hypercalcemia, and failure to thrive in infancy [31]. The
cognitive phenotype for WS includes relative strengths in
verbal short-term memory and language and extreme
weakness in visuospatial construction, including writing,
drawing, and pattern construction [e.g., 32]. A number of
studies have considered the behavioral and emotional
characteristics of individuals with WS [33–41], identifying
such characteristics as anxiety, restlessness, and mood
swings. However, most of these reports did not assess for
DSM-IV diagnoses of anxiety disorders.
Leyfer, Woodruff-Borden, Klein-Tasman, Fricke, and
Mervis [42] examined the prevalence of psychiatric
Table 1 Diagnostic features of the DSM-IV-TR anxiety disorders
Disorder Key diagnostic features
Separation anxiety Excessive anxiety associated with separation from home or caregivers
Panic disorder Panic attacks and persistent concern about the future recurrence of attacks as well as
worry about the consequences of the panic
Specific phobia Excessive fear of specific objects or situations, subsequent avoidance of those,
and/or distress associated with exposure to these objects or situations
Social phobia Excessive fear of social and performance situations and subsequent avoidance
of and/or distress associated with exposure to the situation
Generalized anxiety disorder Excessive worry or anxiety across a number of situations and events, which is hard to control
Obsessive-compulsive disorder Persistent intrusive thoughts that may not make sense and/or repetitive driven behaviors
that the individual performs in response to obsession or in accordance with specific rules
Posttraumatic stress disorder Persistent re-experiencing of a traumatic event through intrusive recollections, dreams, or flashbacks
Acute stress disorder Short-term re-experiencing, dissociation, distress, and avoidance of stimuli associated with
exposure to extreme stress
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the Anxiety Disorders Interview Schedule, Parent version
(ADIS-P) [43], a semi-structured diagnostic interview,
which allows for making differential diagnoses among the
DSM-IV anxiety and mood disorders. The results demon-
strated prevalence rates of 54% for specific phobia, 12% for
generalized anxiety disorder (GAD), 7% for separation
anxiety disorder, 3% for obsessive-compulsive disorder
(OCD), 2% for social phobia, 1% for post traumatic stress
disorder (PTSD), and 1% for panic disorder.
In summary, the preliminary evidence suggests that
anxiety disorders are found at higher prevalence in
individuals with WS, and hence WS may be used to search
for genes implicated in anxiety disorders. However, the
causes of anxiety in individuals with WS are unclear.
Systematic studies of anxiety disorders in individuals with
WS and their first-degree relatives will shed light on the
possible relations between family history of anxiety and
anxiety disorders in individuals with WS and open the door
for further studies of pathophysiology of anxiety. The
purpose of this paper is to provide the first such study.
No studies have examined the prevalence of anxiety
disorders in family members of individuals with WS.
Studies of anxiety in the first degree relatives of children
with other forms of developmental disability (DD) [44–48]
do not clearly demonstrate whether parents of children with
DD have elevated anxiety in comparison to the general
population. However, it is possible that anxiety levels
among parents of children with DD may vary depending on
the child’s behaviors, level of functioning, and other such
variables. Such relations have been reported for parenting
stress. For example, Weiss, Sullivan, and Diamond [49]
demonstrated that lower adaptive functioning scores in
children with DD predict higher levels of parental stress.
Emerson [50] found that the following factors related to
having a child with DD contributed to the prevalence of
mental health problems in the mothers: if the child with DD
is a male, poverty, and the parent’s perception of the social
impact of the child’s difficulties.
Fidler, Hodapp, and Dykens [51] examined which child
variables may affect the levels of stress in families of 20
children with WS, Down syndrome (DS), and Smith–Magenis
syndrome. Results indicated that for the parents of the
children with WS, younger age of the child and maladaptive
behavior as measured by the CBCL Total Problems T score
[52] accounted for 59% of the variance in family stress. These
findings suggest that child variables such as adaptive
functioning and behavioral problems may be predictive of
anxiety in parents of children with WS. Demographic factors
such as employment, child age, and child gender may also
predict anxiety in parents of children with WS.
A few studies of siblings of children with other forms of
DD have been conducted, with contradictory results.
McHale and Gamble [53] reported a significantly higher
anxiety score for siblings of children with intellectual
disability (ID) than for the controls on the Revised Children’s
Manifest Anxiety Scale (RCMAS) [54]. In contrast, using
the same measure, Coleby [55] did not find a difference in
the anxiety score between the two groups of siblings.
In summary, very few studies have investigated anxiety
in parents and siblings of children with DD. The purpose of
the current study was to determine the prevalence of
anxiety disorders in children with WS, their sibling closest
in age, and their mothers and to examine the predictors of
anxiety in these groups, to help determine if hemideletion
of one or more genes in the WS region is likely to
contribute to anxiety disorders.
Method
Participants
The participants were recruited through a study of language
and cognitive development inchildren with WS conducted by
Drs. Carolyn Mervis and Colleen Morris at the University of
Louisville and the University of Nevada School of Medicine.
The University of Louisville site primarily focuses on
cognitive and language development, while the University
of Nevada site focuses on genetic and medical aspects of WS.
Participants eligible for the study included mothers who had
biological children between the ages of 4–16 years with
genetically-confirmed WS. The majority of the families also
had another child in the same age range (half-siblings were
included if they had the same mother). Exclusionary criteria
for the participants were: 1) the presence of another genetic or
developmental disorder in the child with WS (n=11; in all
cases autism or pervasive developmental disorder, not
otherwise specified), 2) the presence of organic brain damage
in the child with WS (n=2), and 3) the presence of a
developmental disorder or organic brain damage in the
mother or the sibling of the child with WS (n=1). The
characteristics of the sample are presented in Table 2.
Measures
Anxiety Disorders Interview Schedule-IV (ADIS-IV) [56] Ma-
ternal diagnostic status was obtained with the ADIS-IV, a
semi-structured diagnostic interview that allows for differ-
ential diagnoses of DSM-IVanxiety and related disorders in
adults. The ADIS-IV provides information both about
specific anxiety disorder diagnoses and their severity [rated
on a scale from 0 (no anxiety) to 8 (very severe anxiety)].
Although no psychometric data are available for the
ADIS-IV, the ADIS-IV: Lifetime Version (ADIS-IV-L) has
been reported to have good to excellent reliability (kappas
6 J Neurodevelop Disord (2009) 1:4–14.58–.81) [57]. Adequate test–retest reliability has also been
reported for the predecessor of the ADIS-IV, the ADIS-
Revised [58], with kappas of.43 to.82.
Anxiety Disorders Interview Schedule, Parent version
(ADIS-P) [42] The ADIS-P is a semi-structured interview
designed to diagnose anxiety disorders in children and
adolescents (through age 16 years). It is based on DSM-IV
criteria and is used both to determine the diagnosis and its
severity. The ADIS-P allows for differential diagnoses
among all the DSM-IV anxiety and related disorders and
provides data regarding symptomatology, etiology, and the
course of the disorder [59]. The ADIS-P also provides
information about the severity of any diagnoses using the
same scale as the ADIS-IV. Silverman, Saavedra, and Pina
[60] found excellent reliability for separation anxiety
disorder, social phobia, specific phobia, and GAD as well
as excellent test–retest reliability for the interview.
Semistructured diagnostic interviews have several
advantages in comparison to questionnaires and rating
scales. First, they provide specific diagnoses based on a
diagnostic system such as the DSM. Thus, symptoms and
behaviors are grouped into diagnostically meaningful
clusters and onset, impairment, and other variables are
taken into account. Second, the interviewer can ask
additional questions or vary the wording of questions in
order to be certain that the informant understands the
question. Third, the interviewer can solicit examples of the
behavior in question, ensuring the accuracy of the data.
The applicability of DSM-IV criteria to populations with
DD has been widely discussed in the literature. Cooper,
Melville, and Einfeld [61] and Reiss, Levitan, and Szyszko
[62] argue that reported prevalence rates of psychopathology
may be an underestimate in populations with DD. Sovner
and Hurley [63–66] suggested that although they may be less
likely to be diagnosed, adults with DD have psychiatric
disturbances that are conceptually the same as DSM
disorders. Brown, Aman, and LeCavalier [67]a r g u e dt h a t
DSM-IV criteria are applicable to children and adolescents
with mild or moderate intellectual disability. The IQs of
5.3% of the children with WS in the present study were in
the range of severe intellectual disability, suggesting that the
results may be a slight underestimate of the actual rates of
anxiety disorders.
Differential Ability Scales (DAS) [68, 69] The DAS
provides an assessment of general intellectual functioning.
This measure was designed to provide specific information
about an individual's strengths and weaknesses across a
wide range of intellectual activities. The General Conceptual
Ability (GCA; similar to IQ) is based on performance on the
core subtests and has a mean of 100 and a standard deviation
of 15.
There are two levels of the DAS: Preschool and School
Age. Following the test author’s recommendation for
children who are expected to have below average intelli-
gence, the Preschool Level was administered to all children
who were 6 years 11 months or younger. The School Age
Level was administered to the remaining children unless
they were very low functioning; these children completed
the Preschool Level. If necessary, the GCA was calculated
using the extended norms, which are available for the
Table 2 Demographic
information
1 No difference found in
income between families with
employed and unemployed
mothers (p=.772).
Note. DAS GCA = Differential
Ability Scales General Concep-
tual Ability score; M(SD) =
Mean (standard deviation);
SIB-R Broad Ind = Scales of
Independent behavior-Revised
Broad independence score.
Children with WS Siblings Mothers
N 132 84 132
Age M (SD), Range 8.5 (3.3), 4.0–16.9 9.7 (3.1), 4.2–16.6 38.7 (5.9), 22.7–58.2
Sex N (%)
Males 63 (47.7%) 44 (52.4%)
Females 60 (52.3%) 40 (47.6%)
DAS GCA M (SD), Range 60.2 (13.6), <25–94
SIB-R Broad Ind.
M (SD), Range 55.9 (14.3), 15–95
Marital status N (%)
Married 113 (86%)
Divorced 15 (11%)
Single 4 (3%)
Income N (%)
<$30,000 16 (12%)
$21–60,000 26 (20%)
$61–90,000 45 (34%)
>$91,000 45 (34%)
Employment N (%)
1
Employed N=72 (54.5%)
Unemployed N=40 (45.5%)
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Scales of Independent Behavior-Revised (SIB-R) [70] The
SIB-R provides an assessment of adaptive behavior. The
parent interview form of the instrument was administered.
It consists of 259 items; each item is scored on a 4-point
Likert scale. The items are divided into four clusters: Motor
Skills, Social Interaction and Communication, Personal
Living Skills, and Community Living Skills. The Broad
Independence standard score is based on parental responses
to items in all four clusters. This standard score has a mean
of 100 and a standard deviation of 15. Additionally, the
SIB-R assesses three domains of maladaptive behavior:
Internalized, Asocial, and Externalized. The norms for the
SIB-R extend from age 3 months to 90 years.
Child Behavior Checklist (CBCL) [71, 72] The CBCL is a
Likert scale that provides an assessment of behavioral and
emotional problems of children from parents and/or other
caregivers. There are two versions of this instrument: one
for children aged 1 1/2–5 years and another for children
aged 6–18 years. The Total Problems T score was used as a
measure of behavioral problems in this study.
Training/reliability of student clinical interviewers
All interviewers who administered the ADIS-IVand ADIS-P
had successfully completed reliability training for the
interview. Training for the ADIS consisted of the following
components: reviewing the interview, observing videotaped
or live administrations of the interview, and assigning
diagnoses and severity ratings for each interview. Inter-
viewers were required to obtain three consecutive matches
on diagnosis and its severity. Upon completion of this
process, the interviewer administered a practice ADIS. This
interview was videotaped and was rated by a licensed
clinical psychologist. If the interviewer and the clinical
psychologist diagnoses matched on principal and additional
diagnoses as well as severity, the interviewer was permitted
to administer the ADIS for the study. All interview protocols
were reviewed with a licensed clinical psychologist. Dis-
agreements were resolved by discussion.
Results
Prevalence rates of anxiety disorders in children with WS
Prevalence rates for each type of anxiety disorder in
children with WS are shown in Table 3. Overall, 62.1%
of the children received a diagnosis of at least one anxiety
disorder. The most prevalent anxiety disorder was specific
phobia, found in 56.1% of the children. These prevalence
rates were compared to those in the general population of
children using a z-test, with the significance level set at.05.
For this comparison, the findings of the Child and
Adolescent Mental Disorders Study [3], the largest epide-
miological study of psychiatric disorders in children in the
USA using a reliable and valid structured diagnostic
interview, the Diagnostic Interview Schedule for Children
Version 2.3 (DISC-2.3) [3], were used (Table 3). We also
compared these data to the prevalence rates of anxiety
disorders in the largest epidemiological study of psychiatric
disorders in children with DD [73], using the DISC-IV
[74]. The children with WS had a significantly higher
prevalence of specific phobia, GAD, and separation anxiety
than did children either in the general population or an
epidemiological sample of children with DD.
The prevalence rates of types of anxiety disorders were
also compared between children with WS who had a sibling
Table 3 Prevalence of anxiety disorders in children with WS (N=132), children in the general population, and children in the DD population
Type of anxiety disorder WS Population prevalence
a DD population prevalence
b
N %% %
Separation anxiety disorder 8 6.1 2.3* 1.9*
Social phobia 3 2.3 4.5 1.9
GAD 10 7.6 3.1* 0**
OCD 2 1.5 –
c 1.5
Specific phobia 74 56.1 1.3** 6.8**
PTSD 2 1.5 –
c –
c
*p<.01; **p<.001
aPrevalence established using the Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3), Parent version
bPrevalence established using the DISC-IV, Parent version
cPrevalence not reported.
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significant difference was found in the prevalence of either
anxiety disorders in general or specific anxiety disorders
between the two groups.
Prevalence rates of anxiety disorders in mothers of children
with WS
Lifetime prevalence of each type of anxiety disorder for the
mothers participating in the study is reported in Table 4.T h e
prevalence for each anxiety disorder was then compared to
the prevalence in the general population of women in the
same age range, using a z test, with a significance level of
p<.05. For population prevalence, the findings of the
National Comorbidity Study Replication (NCS-R) were used
[75; Table 4], adjusted to include the age range of the
participants in the present study. The prevalence of GAD in
the mothers of children with WS was significantly higher
than in the general population of women.
To control for the influence of having a child with DD,
the prevalence of GAD in the mothers prior to the birth of
their child with WS was examined, taking into consideration
the date of onset of GAD as reported by the mothers. This
prevalence (6.4%) was similar to that for the general
population (z=0.2, p=.827).
Prevalence rates of anxiety disorders in siblings of children
with WS
Prevalence rates of each type of anxiety disorder in siblings
of children with WS (N=84) are reported in Table 5.
Overall, 25% of the siblings had a diagnosis of at least one
anxiety disorder. The prevalence of each anxiety disorder
and of any anxiety disorder was compared to the prevalence
in the general population of children with typical develop-
ment (TD), using a z test, with a significance level of
p<.05. For population prevalence, the findings of the Child
and Adolescent Mental Disorders Study [3; Table 3] were
used. The siblings of children with WS had a significantly
higher prevalence of specific phobia (p<.001) than Shaffer
et al. reported for children in the general population.
The prevalence rates of anxiety disorders overall in
children with WS were then compared to the prevalence in
their TD siblings, using the McNemar test, a statistic used
to test matched-pair data [76], with a significance level of
p<.05. To control for environmental and genetic influences,
only the subset of children with WS who had a sibling
participating in the study (N=84) was used for this analysis.
(No difference was found in the prevalence of anxiety
disorders between children with WS with and without
siblings in the 4–16 year age range.) The children with WS
had a significantly higher prevalence of anxiety disorders
overall than their siblings (p<.001). The children with WS
also had a significantly higher prevalence of specific phobia
than their siblings (p<.001). Comparisons for the remaining
categories of anxiety disorders were not performed because
of the low expected frequencies for some of the cells. Note,
however, that the prevalence of GAD for the children with
WS was almost double that of their siblings and that the
prevalence of social phobia for the children with WS was
one-third that of their siblings.
Predictors of anxiety in children with WS
A logistic regression was conducted to determine the
factors related to the presence of anxiety disorders in
children with WS. The child’s DAS GCA score, the age of
the child with WS, the sex of the child with WS, and
severity of maternal anxiety (M=1.6, SD=2.2) were
Table 5 Prevalence of anxiety disorders in children with WS and
their siblings
Type of anxiety disorder TD (N=84) WS (N=84)
N % N %
Any anxiety disorder 21 25.0 51 60.7*
Separation anxiety 3 3.6 3 3.6
Social phobia 6 7.1 2 2.4
GAD 5 6.0 9 10.7
OCD 0 0 2 2.4
Specific phobia 14 16.7 44 52.4*
*p<.001
Table 4 Prevalence of anxiety disorders in mothers of children with
WS (N=132)
Type of anxiety disorder N % Population
Prevalence (%)
a
Social phobia 15 11.4 15.7
GAD 31 23.5 8.1**
OCD 3 2.3 1.6
Specific phobia 27 20.5 17.9
PTSD 5 3.8 10.9*
Panic disorder 4 3.0 7.7
*p<.01; **p<.001
aPrevalence assessed using the Composite International Diagnostic
Interview
Table 6 Logistic regression analysis summary for predictors of
anxiety in children with WS
Model Β SE Odds ratio
Age .03 .06 1.03
Sex −.58 .42 .56
DAS GCA −.02 .02 .98
Severity of maternal anxiety .42 .12 1.52*
*p<.01
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equation was significant, χ
2 (4)=22.06, p<.001. The model
accounted for 22.0% of the variance in the anxiety in the
child with WS. The odds of a child with WS having an
anxiety disorder increased with the severity of maternal
anxiety.
Predictors of anxiety in mothers of children with WS
A logistic regression analysis was conducted to determine
the extent to which the age, IQ, overall behavioral problems
of the child with WS, and maternal employment status
predicted the presence of maternal anxiety. For this
analysis, the mothers who reported the onset of their
anxiety as occurring before having a child with WS were
excluded (n=14). The age of the child with WS, the child’s
DAS GCA, the child’s CBCL Total Problems T score, and
maternal employment status were entered as covariates
(Table 7). The overall regression equation was significant,
χ
2 (4)=10.1, p=.039, the model accounting for 12.0% of
the variance of the presence of anxiety in mothers. The
odds of the mother having an anxiety disorder increased
significantly as the child’s GCA decreased and marginally
if the mother was employed outside of home.
Predictors of anxiety in siblings of children with WS
A logistic regression was conducted to test whether maternal
anxiety, sibling age, and sibling sex predicted anxiety in the
siblings. The overall regression equation was not significant,
χ
2 (3)=3.6, p=.312, the model predicting only 7% of the
variance. The prevalence rates of anxiety disorders overall in
the siblings were then compared to the prevalence in their
mothers, using the McNemar test, a statistic used to test
matched-pair data [76], with a significance level of p<.05.
For this analysis, we excluded the mothers who had the onset
of anxiety after having a child with WS. No significant
results were obtained (p=.332). Spearman’sr h ow a sc o m -
puted to investigate whether sibling anxiety correlated with
the CA (−.14), severity of anxiety (.20), DAS GCA (−.11),
SIB-R Broad Independence (−.05), or CBCLTotal Problems
Tscore (.10) of children with WS. None of these correlations
was significant.
Discussion
The present study investigated the prevalence of anxiety
disorders in children with WS, their mothers, and their
siblings, using a DSM-IV-based semi-structured diagnostic
interview with good psychometric properties. In addition,
this study investigated potential predictors of anxiety in
children with WS, their mothers, and their siblings. The
results are discussed in the order of groups in the study:
children with WS, their mothers, and their siblings. The
final section focuses on the implications of these findings
for the genetics of anxiety disorders.
Children with WS
The results of this study demonstrate that children with WS
have elevated rates of anxiety disorders in comparison to
children in the general population. When examined by type,
children with WS have a significantly higher prevalence of
specific phobia, GAD, and separation anxiety than children
in the general population. The same pattern was found
when the prevalence of anxiety disorders in children with
WS was compared to that in an epidemiological sample of
children with DD of mixed etiology [73].
These rates are also much higher than those previously
reported for individuals with DD of other etiologies. Myers
and Pueschel [77] reported phobias in only 1.5% of their
sample of children and adolescents with Down syndrome.
Backes et al. [78] reported separation anxiety in 10% and
OCD in 2% of children with Fragile X syndrome. In a
study of prevalence of psychiatric disorders in 264 children
with DD of mixed etiology, Emerson [79] reported 1.9%
prevalence of specific phobia and 2.7% prevalence of
separation anxiety. In the present study, the children with
WS also had a significantly higher prevalence of specific
phobia than their siblings. No comparisons with siblings
were made for other anxiety disorders because of the low
frequency in both groups.
The presence of maternal anxiety may further increase
the rate of anxiety disorders in children with WS. Studies of
children with TD have already demonstrated that the risk
for anxiety disorders is higher for children of anxious
parents than children of parents without anxiety [13–16].
However, children with WS have a much higher prevalence
rate of anxiety disorder (62.1%) than that reported for
children of anxious parents (33%) [80].
These findings overall demonstrate an elevated rate of
anxietydisordersinchildrenwithWS,whichperKarayiorgou
and Gogos [25] is one of the two criteria demonstrating a
causal relation between a chromosomal abnormality and a
disease, in this case 7q11.23 deletion and anxiety. It appears
that the deletion increases the risk for developing an anxiety
disorder in children with WS. The logistic regression results
Table 7 Logistic regression analysis summary for predictors of
anxiety in mothers of children with WS
Model Β SE Odds ratio
Age of the child with WS .06 .06 1.06
DAS GCA −.03 .02 .96*
Total problem behavior .02 .03 1.02
Maternal employment −.77 .42 .46**
*p<.05; **p=.07
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contribute to the risk of developing an anxiety disorder in
children with WS. This finding is consistent with results of
family studies of anxiety disorders. An important focus for
future research is to further investigate the separate and
combined contributions of particular deleted gene(s) and
history of maternal anxiety to anxiety in children with WS.
Mothers of children with WS
In this study, mothers of children with WS reported a
significantly higher lifetime prevalence of GAD than
women in the general population. Because no large studies
have examined the prevalence of anxiety disorders in
mothers of children with DD, no statistical comparisons
were conducted with such populations. However, the
mothers of children with WS also had a notably higher
prevalence of anxiety disorders than mothers of children
with Down syndrome or autism in previous studies, which
have reported rates similar to or lower than those in the
general population [47–48].
When the age of onset of GAD in the mothers was taken
into account, it appeared that the prevalence rate for GAD
for mothers of children with WS prior to the birth of the
child with WS (as reported by the mothers in retrospect)
was comparable to that for women in the general
population, suggesting that maternal GAD may be at least
in part related to the stress of raising a child with WS. One
question is why mothers of children with WS have
increased prevalence of GAD rather than of other types of
anxiety disorders. It is possible that the diagnostic criteria
for GAD (excessive worry or anxiety across a number of
situations and events, which is difficult to control) [8]
encompass the stressors directly associated with raising a
child with WS, such as health, school, and behavior as well
as stressors likely due to having a child with WS, but
involving other family members, including spousal rela-
tions and parental relations with TD children. This finding
is consistent with previous findings on the onset of GAD,
demonstrating that later-onset GAD is associated with the
emergence of life stressors [e.g., 81–83]. A potential
limitation of this finding is that the onset of maternal
GAD is based on a retrospective report by the mothers, and
it is possible that the report is inaccurate and the mothers of
children with WS have a higher prevalence of GAD than
the women in the general population even prior to having
the child with WS.
In the present study, child IQ significantly affected the
odds of a mother having an anxiety disorder, suggesting
that higher IQ was associated with decreased odds of the
mother having an anxiety disorder. Additionally, mothers
who were not employed outside of the home also had a
marginally increased likelihood of having an anxiety
disorder relative to mothers who were employed outside
of the home. This difference was not due to lower family
income; family income in families where the mothers were
not employed was very similar to family income where the
mothers were employed. This finding is consistent with that
of Wittchen et al. [84], who found that in the National
Comorbidity Survey being unemployed and being a
homemaker were significantly correlated with the presence
of GAD.
Overall, these findings suggest that the mothers of
children with WS are at increased risk for developing an
anxiety disorder later in life, which may be due to the
environmental stress of raising a child with WS. It is
possible that some of the mothers of children with WS may
have a predisposition to developing an anxiety disorder
which then becomes apparent in the presence of an
environmental stressor. This is consistent with evidence
from genetic studies. For example, in a study of 1,033
blindly assessed female–female twin pairs, Kendler et al.
[85] estimated 30% heritability for GAD and postulated
that the remainder of the variance may be accounted for by
environmental factors.
Several steps may be taken to explore this issue further.
First, studies are needed to compare the prevalence rates of
anxiety disorders in mothers of children with WS with
those of mothers of children with other types of DD.
Second, larger studies examining potential environmental
stressors in these mothers may also help clarify the relation
between these stressors and the onset of anxiety. Examina-
tion of the interaction of the potential anxiety candidate
genes and environmental influences and its effect on
anxiety in this population will help explain the prevalence
findings in the mothers and advance our knowledge of the
etiology of anxiety disorders.
Siblings of children with WS
The siblings of children with WS had the same prevalence
of anxiety disorders as children in the general population as
measured by Shaffer et al. [3], with the exception of
specific phobia. However, while the prevalence of specific
phobia in siblings of children with WS was higher than that
reported by Shaffer et al. [3], it was similar to the rates
reported in other studies of specific phobia in children with
TD [86, 87]. Lichtenstein and Annas [86] examined the
prevalence of specific phobia in 1106 pairs of 8–9-year-old
twins (both DZ and MZ), using a DSM-IV based
questionnaire, and reported a rate of 8.6%. Muris and
Merckelbach [87] administered the specific phobia sections
of the DISC-2.3 [3] to parents of 160 children aged 4–
12 years and found a 17.6% prevalence of specific phobia.
These findings suggest that the prevalence rate of specific
phobia in the children in general population reported in
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siblings of children with WS would not evidence increased
prevalence of any anxiety disorder relative to children in
the general population.
Neither history of maternal anxiety nor any factors
related to the sibling with WS, such as IQ, behavior
problems, or severity of anxiety disorder in the child with
WS, predicted or correlated with the presence of anxiety
disorder in the siblings. These results may be due to the
small number of siblings who had an anxiety disorder. A
study with a larger number of siblings of children with WS
who have anxiety may be successful at identifying
predictors of anxiety in the siblings. Additionally, compar-
ison groups of siblings of children with DD and siblings of
children from families in which all children are typically
developing may help further clarify these findings.
Implications for genetic research on anxiety disorders
Research on complex disorders has demonstrated that
examination of neurodevelopmental disorders of known
genetic cause that are associated with high prevalence rates
of a particular psychiatric disorder may be successful in
identifying susceptibility genes for these disorders. Thus far
this approach has not been applied to anxiety disorders.
These and previous findings by Leyfer et al. [42] indicate
that there may be a causal relation between anxiety and
deletion of chromosome 7q11.23 [26]. It is thus possible
that there is a susceptibility locus for anxiety on 7q11.23.
This possibility can be further tested by means of genetic
linkage and association studies. From this point on several
strategies may be implemented to identify how 7q11.23
deletion may contribute to anxiety. For example, hemi-
deletion of one or more genes in the WS region may cause
increased anxiety. To test this possibility, association
studies may be conducted on genes contained in the deleted
region, using samples of TD individuals with and without
an anxiety disorder.
It is also possible that the increased prevalence of
anxiety in WS is due to the impact of the deletion of one
or more genes in the deleted region on genes outside that
region that are involved in anxiety. To test this possibility,
association studies on anxiety can be conducted with
individuals with WS targeting genes that have already been
implicated in anxiety. Although the findings of association
studies of anxiety disorders are conflicting thus far, several
genes may be of potential interest. COMT, an enzyme
responsible for the metabolism of noradrenaline and
dopamine, encoded by a gene located on 22q11 [9] has
been implicated in panic disorder [87] and OCD [88, 89].
Another gene that may be of potential interest is a variant of
the serotonin transporter (SERT) gene, implicated in
personality traits related to anxiety [90, 91]. These genes
can also be investigated in the mothers of children with
WS.
When conducting association studies, several problems
may arise. First, the selection of the control group will
affect the results tremendously, because the differences
between the two groups may not be related to genetics. For
example, differences in allele frequencies may vary among
different subgroups. To minimize such problems, Arnold et
al. [10] suggest using family-based association methods.
The mothers and siblings of children with WS can serve as
the comparison group in future association studies. Future
studies will need to focus on examining the prevalence of
anxiety disorders in fathers of children with WS to
determine the impact of paternal anxiety on anxiety in
children with WS. It would also be useful to conduct large
scale comparison studies of anxiety disorders and their
predictors in children with WS, their siblings, and their
parents and children with other types of DD, their siblings,
and their parents.
In conclusion, given the increased prevalence of anxiety
disorders in children with WS, genetic studies examining
possible links between particular genes deleted in WS and
anxiety are warranted. It would also be worthwhile to
investigate possible relations between genes deleted in WS
and genes outside the deleted region that have been
previously implicated in anxiety disorders in the general
population. Research in this area likely will yield valuable
new findings for determining the etiology of anxiety
disorders in the general population.
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